A concise review on advances in development of small molecule anti-inflammatory therapeutics emphasising AMPK: An emerging target.
作者： U. Gejjalagere Honnappa , C. , Mazhuvancherry Kesavan , None
关键词: Small molecule 、 AMPK 、 Multi target 、 Anti-inflammatory 、 Cyclooxygenase 、 Cancer research 、 Inflammation 、 Medicine 、 Pharmacology 、 Tissue repair
摘要: Inflammatory diseases are complex, multi-factorial outcomes of evolutionarily conserved tissue repair processes. For decades, non-steroidal anti-inflammatory drugs and cyclooxygenase inhibitors, th...
sagepub.com
elsevier.com
sci-hub.se 参考文章(38)
K.D. Rainsford, Anti-inflammatory drugs in the 21st century. Sub-cellular biochemistry. ,vol. 42, pp. 3- 27 ,(2007) , 10.1007/1-4020-5688-5_1
Tanya S. King, Otto Quintus Russe, Christine V. Möser, Nerea Ferreirós, Katharina L. Kynast, Claudia Knothe, Katrin Olbrich, Gerd Geisslinger, Ellen Niederberger, AMP-activated protein kinase is activated by non-steroidal anti-inflammatory drugs. European Journal of Pharmacology. ,vol. 762, pp. 299- 305 ,(2015) , 10.1016/J.EJPHAR.2015.06.001
Jonathan A. Lee, Paul Shinn, Susan Jaken, Sarah Oliver, Francis S. Willard, Steven Heidler, Robert B. Peery, Jennifer Oler, Shaoyou Chu, Noel Southall, Thomas S. Dexheimer, Jeffrey Smallwood, Ruili Huang, Rajarshi Guha, Ajit Jadhav, Karen Cox, Christopher P. Austin, Anton Simeonov, G. Sitta Sittampalam, Saba Husain, Natalie Franklin, David J. Wild, Jeremy J. Yang, Jeffrey J. Sutherland, Craig J. Thomas, Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of Assays PLOS ONE. ,vol. 10, pp. e0130796- ,(2015) , 10.1371/JOURNAL.PONE.0130796
David Grahame Hardie, Regulation of AMP-activated protein kinase by natural and synthetic activators Acta Pharmaceutica Sinica B. ,vol. 6, pp. 1- 19 ,(2016) , 10.1016/J.APSB.2015.06.002
Geetha Mathew, M. K. Unnikrishnan, Multi-target drugs to address multiple checkpoints in complex inflammatory pathologies: evolutionary cues for novel “first-in-class” anti-inflammatory drug candidates: a reviewer’s perspective Inflammation Research. ,vol. 64, pp. 747- 752 ,(2015) , 10.1007/S00011-015-0851-8
Curtis A. Carlson, Ki-Han Kim, Regulation of Hepatic Acetyl Coenzyme A Carboxylase by Phosphorylation and Dephosphorylation Journal of Biological Chemistry. ,vol. 248, pp. 378- 380 ,(1973) , 10.1016/S0021-9258(19)44486-4
Jun Suzuki, Takeru Yoshimura, Marina Simeonova, Kimio Takeuchi, Yusuke Murakami, Yuki Morizane, Joan W. Miller, Lucia Sobrin, Demetrios G. Vavvas, Aminoimidazole Carboxamide Ribonucleotide Ameliorates Experimental Autoimmune Uveitis Investigative Ophthalmology & Visual Science. ,vol. 53, pp. 4158- 4169 ,(2012) , 10.1167/IOVS.11-9323
B. Viollet, R. Mounier, J. Leclerc, A. Yazigi, M. Foretz, F. Andreelli, Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders Diabetes & Metabolism. ,vol. 33, pp. 395- 402 ,(2007) , 10.1016/J.DIABET.2007.10.004
Geetha Mathew, Magith Thambi, M.K. Unnikrishnan, A multimodal Darwinian strategy for alleviating the atherosclerosis pandemic Medical Hypotheses. ,vol. 82, pp. 159- 162 ,(2014) , 10.1016/J.MEHY.2013.11.025
Kimio Takeuchi, Yuki Morizane, Cynthia Kamami-Levy, Jun Suzuki, Maki Kayama, Wenyi Cai, Joan W. Miller, Demetrios G. Vavvas, AMP-dependent kinase inhibits oxidative stress-induced caveolin-1 phosphorylation and endocytosis by suppressing the dissociation between c-Abl and Prdx1 proteins in endothelial cells. Journal of Biological Chemistry. ,vol. 288, pp. 20581- 20591 ,(2013) , 10.1074/JBC.M113.460832